跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25 条关于
“PharmaTher”
全部
25
临床试验
1
药物
5
机构
10
资讯
9
4年前
PharmaTher Secures U.S. Patent for Advanced Ketamine Production Technology
10个月前
PharmaTher Secures Exclusive Rights to Long-Acting Injectable Ketamine Technology for Treatment-Resistant Depression
2年前
PharmaTher Receives FDA Goal Date of October 29, 2024 for Priority Ketamine ANDA Approval
6个月前
PharmaTher Advances Microneedle Patch Platform for Therapeutic Peptides with PatchPrint Manufacturing System
去年
PharmaTher on Track for Ketamine FDA Resubmission, Anticipates Q2 2025 Approval
2年前
PharmaTher Sets August 2025 FDA Approval Goal Date for Ketamine Product, Confirms Full Funding Through Commercial Launch
去年
FDA Issues Second Complete Response Letter for PharmaTher's Ketamine ANDA
上个月
PharmaTher Partners with KetaMist Inventor to Pursue FDA Approval for Needle-Free Ketamine Platform in Treatment-Resistant Depression
18天前
FDA Issues Untitled Letter to Alar Pharmaceuticals Over Promotion of Unapproved Ketamine Drug ALA-3000